^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners

    TEST:
    FITRapid

    Company:
    MiRXES
    Type:
    Other Approval
    Related tests:
    Details
    Evidence

    News

    13d
    Mirxes to Advance Cancer Screening in Thailand via Strategic N Health Partnership and Launch of First-of-its-Kind At-Home Diagnostic Kits (Mirxes Press Release)
    Mirxes...announced the Thailand launch of its new range of at-home screening test kits: FITRapid and HELICORapid, following Thailand FDA approvals in October 2025 and December 2025 respectively. FITRapid is designed to detect fecal occult blood, an indicator of cancer or polyps in the colon or rectum, while HELICORapid is designed to detect Helicobacter pylori (H. pylori) infection, a major and the strongest known risk factor for stomach cancer.
    Clinical • Launch
    |
    FITRapid • HELICORapid